We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+8.55%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$11.4B
AUM Growth
+$476M
Cap. Flow
-$300M
Cap. Flow %
-2.64%
Top 10 Hldgs %
22.33%
Holding
2,538
New
224
Increased
309
Reduced
1,136
Closed
102

Top Sells

Rank Stock Value
1
MPLX icon
MPLX
MPLX
+$20.7M
2
AAPL icon
Apple
AAPL
+$16M
3
BSV icon
Vanguard Short-Term Bond ETF
BSV
+$15.6M
4
MSFT icon
Microsoft
MSFT
+$13M
5
WMB icon
Williams Companies
WMB
+$9.28M

Sector Composition

Rank Sector Weight
1 Technology 20.93%
2 Financials 13.29%
3 Healthcare 12.64%
4 Consumer Discretionary 11.46%
5 Industrials 9.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRDO icon
1851
Perdoceo Education
PRDO
$1.99B
$316K ﹤0.01%
25,776
+7,924
+44% +$96.8K
HGEN
1852
DELISTED
HUMANIGEN, INC.
HGEN
$316K ﹤0.01%
+18,193
New +$332K
PCT icon
1853
PureCycle Technologies
PCT
$1.41B
$315K ﹤0.01%
+13,329
New +$287K
SRI icon
1854
Stoneridge
SRI
$201M
$315K ﹤0.01%
10,678
UUUU icon
1855
Energy Fuels
UUUU
$3.64B
$314K ﹤0.01%
51,929
+18,293
+54% +$112K
BANC icon
1856
Banc of California
BANC
$3.11B
$313K ﹤0.01%
17,872
APPH
1857
DELISTED
AppHarvest, Inc. Common Stock
APPH
$313K ﹤0.01%
+19,545
New +$312K
AVO icon
1858
Mission Produce
AVO
$1.15B
$313K ﹤0.01%
+15,099
New +$309K
NX icon
1859
Quanex
NX
$981M
$313K ﹤0.01%
12,585
NRIX icon
1860
Nurix Therapeutics
NRIX
$2.82B
$312K ﹤0.01%
11,779
+2,269
+24% +$66.6K
SLCA
1861
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$312K ﹤0.01%
27,031
+7,129
+36% +$82.7K
WRLD icon
1862
World Acceptance Corp
WRLD
$875M
$312K ﹤0.01%
1,945
SRRK icon
1863
Scholar Rock
SRRK
$6.46B
$311K ﹤0.01%
10,772
TVTX icon
1864
Travere Therapeutics
TVTX
$5.79B
$311K ﹤0.01%
21,324
GEO icon
1865
The GEO Group
GEO
$4B
$309K ﹤0.01%
43,461
+9,788
+29% +$61.6K
UTL icon
1866
Unitil
UTL
$992M
$308K ﹤0.01%
5,823
AGM icon
1867
Federal Agricultural Mortgage
AGM
$2.51B
$308K ﹤0.01%
3,118
-1,145
-27% -$116K
CHUY
1868
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
$308K ﹤0.01%
8,272
BHE icon
1869
Benchmark Electronics
BHE
$2.89B
$307K ﹤0.01%
10,799
-4,114
-28% -$124K
ANIK icon
1870
Anika Therapeutics
ANIK
$283M
$307K ﹤0.01%
7,087
SWIM icon
1871
Latham Group
SWIM
$889M
$307K ﹤0.01%
+9,595
New +$280K
VLDR
1872
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
$306K ﹤0.01%
+28,748
New +$339K
ZY
1873
DELISTED
Zymergen Inc. Common Stock
ZY
$305K ﹤0.01%
+7,633
New +$301K
STRO icon
1874
Sutro Biopharma
STRO
$353M
$305K ﹤0.01%
1,642
+334
+26% +$65.4K
AVTA
1875
DELISTED
Avantax, Inc. Common Stock
AVTA
$304K ﹤0.01%
17,555
+5,463
+45% +$89.7K

Similar funds

MetLife Investment Management's Q2 2021 Portfolio in Review

As of Q2 2021, MetLife Investment Management held 2,538 positions worth $11.4B, up 4.4% from $10.9B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

MetLife Investment Management's Q2 2021 filing shows 224 new, 309 increased, 1,136 reduced and 102 closed positions. Its largest new stake was UiPath: 142,126 shares worth $9.65M. The largest sale was MPLX, an estimated $20.7M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

  • MetLife Investment Management's largest Q2 2021 buy was UiPath: 142,126 shares worth $9.65M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $24.1M increase.
  • MetLife Investment Management's biggest Q2 2021 reduction was Apple, cutting an estimated $16M.
  • MetLife Investment Management fully exited MPLX in Q2 2021, selling an estimated $20.7M.
  • MetLife Investment Management's ten largest holdings make up 22% of its $11.4B portfolio in Q2 2021.
  • MetLife Investment Management opened 224 new positions and closed 102 in Q2 2021.
  • MetLife Investment Management's portfolio value rose 4.4% quarter-over-quarter to $11.4B.

Based on MetLife Investment Management's 13F filing for Q2 2021, filed 16 Aug 2021.